<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39493003</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-6861</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in rehabilitation sciences</Title><ISOAbbreviation>Front Rehabil Sci</ISOAbbreviation></Journal><ArticleTitle>Distinguishing pain profiles among individuals with long COVID.</ArticleTitle><Pagination><StartPage>1448816</StartPage><MedlinePgn>1448816</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1448816</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fresc.2024.1448816</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">For many people with long COVID (LC), new-onset pain is a debilitating consequence. This study examined the nature of new-onset pain and concomitant symptoms in patients with LC to infer mechanisms of pain from the relationships between pain and health-related factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Pain and other symptoms were evaluated in 153 individuals with LC using the Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs, EuroQoL Visual Analog Scale, and Quality of Life in Neurological Disorders. The relationships between pain and patient factors were analyzed using Chi Square and independent <i>t</i>-tests.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">20.3% of individuals who reported new-onset pain had neuropathic pain, which was associated with lower quality of life and higher rates of cognitive dysfunction compared to those with non-neuropathic pain. Other symptoms were similar between groups, however heart-related symptoms were more prevalent in individuals with neuropathic pain and mood swings were more prevalent for individuals with non-neuropathic pain.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Characterizing the relationships between NP and quality of life in individuals with LC can aid in developing better clinical management strategies. Understanding the associations between NP and cognitive dysfunction provides the imperative foundation for future studies further examining the pathophysiological mechanisms underlying pain development in LC.</AbstractText><CopyrightInformation>&#xa9; 2024 Tabacof, Chiplunkar, Canori, Howard, Wood, Proal and Putrino.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tabacof</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chiplunkar</LastName><ForeName>Maanas</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rusk Rehabilitation, Department of Physical Medicine and Rehabilitation, New York University Grossman School of Medicine, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canori</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proal</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Polybio Research Foundation, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putrino</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Rehabil Sci</MedlineTA><NlmUniqueID>9918227358906676</NlmUniqueID><ISSNLinking>2673-6861</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">cognitive function</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuropathic</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39493003</ArticleId><ArticleId IdType="pmc">PMC11527737</ArticleId><ArticleId IdType="doi">10.3389/fresc.2024.1448816</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. (2023) 23(4):393&#x2013;5. 10.1016/S1473-3099(23)00053-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EclinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccarone MC, Coraci D, Regazzo G, Masiero S. Symptoms patterns and health-related quality of life in a real-life cohort of long COVID patients: understanding the complexity to optimize the rehabilitation treatment. Am J Phys Med Rehabil. (2024). 10.1097/PHM.0000000000002578</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000002578</ArticleId><ArticleId IdType="pubmed">38958179</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O, Silva Passadouro B, Mulvey M, Delis I, Astill S, Tan AL, et al. Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J Pain Res. (2022) 15:1729&#x2013;48. 10.2147/JPR.S365026</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmans RS, Clauw DJ, Flint C, Harris H, Lederman S, Schrepf A. Chronic overlapping pain conditions increase the risk of long COVID features, regardless of acute COVID status. PAIN. (2024) 165(5):1112&#x2013;20. 10.1097/j.pain.0000000000003110</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000003110</ArticleId><ArticleId IdType="pmc">PMC11017744</ArticleId><ArticleId IdType="pubmed">38112577</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaturro D, Vitagliani F, Di Bella VE, Falco V, Tomasello S, Lauricella L, et al. The role of acetyl-carnitine and rehabilitation in the management of patients with post-COVID syndrome: case-control study. Appl Sci. (2022) 12(8):4084. 10.3390/app12084084</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12084084</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco T, Gomes V, Rossi A, Cantisani C, Greco ME, Rossi G, et al. The pathological culprit of neuropathic skin pain in long COVID-19 patients: a case series. J Clin Med. (2022) 11(15):4474. 10.3390/jcm11154474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154474</ArticleId><ArticleId IdType="pmc">PMC9369885</ArticleId><ArticleId IdType="pubmed">35956094</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. (2005) 6(3):149&#x2013;58. 10.1016/j.jpain.2004.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2004.11.007</ArticleId><ArticleId IdType="pubmed">15772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. (2022) 101(1):48&#x2013;52. 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, et al. Two-year longitudinal study reveals that long COVID symptoms peak and quality of life nadirs at 6&#x2013;12 months postinfection. Open Forum Infect Dis. (2024) 11(3):ofae027. 10.1093/ofid/ofae027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofae027</ArticleId><ArticleId IdType="pmc">PMC10917418</ArticleId><ArticleId IdType="pubmed">38449921</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res. (2014) 23(3):977&#x2013;89. 10.1007/s11136-013-0537-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-013-0537-z</ArticleId><ArticleId IdType="pmc">PMC4287662</ArticleId><ArticleId IdType="pubmed">24081873</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro-QoL. Available online at:
https://www.healthmeasures.net/explore-measurement-systems/neuro-qol
(retrieved July 24, 2023).</Citation></Reference><Reference><Citation>Score Cut Points. Available online at:
https://www.healthmeasures.net/score-and-interpret/interpret-scores/neuro-qol/neuro-qol-score-cut-points
(retrieved February 22, 2024).</Citation></Reference><Reference><Citation>Williams LD, Zis P. COVID-19-related neuropathic pain: a systematic review and meta-analysis. J Clin Med. (2023) 12(4):1672. 10.3390/jcm12041672</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041672</ArticleId><ArticleId IdType="pmc">PMC9966617</ArticleId><ArticleId IdType="pubmed">36836207</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. (2021) 8(5):1073&#x2013;85. 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zis P, Ioannou C, Artemiadis A, Christodoulou K, Kalampokini S, Hadjigeorgiou GM. Prevalence and determinants of chronic pain post-COVID; cross-sectional study. J Clin Med Res. (2022) 11(19):5569. 10.3390/jcm11195569</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195569</ArticleId><ArticleId IdType="pmc">PMC9573502</ArticleId><ArticleId IdType="pubmed">36233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarty O, Finn DP. Cognition and pain. Palliat Support Care. (2014) 8(2):130&#x2013;6. 10.1097/SPC.0000000000000054</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPC.0000000000000054</ArticleId><ArticleId IdType="pubmed">24722475</ArticleId></ArticleIdList></Reference><Reference><Citation>Povedano M, Gasc&#xf3;n J, G&#xe1;lvez R, Ruiz M, Rejas J. Cognitive function impairment in patients with neuropathic pain under standard conditions of care. J Pain Symptom Manage. (2007) 33(1):78&#x2013;89. 10.1016/j.jpainsymman.2006.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2006.07.012</ArticleId><ArticleId IdType="pubmed">17196909</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R, Eid RA, Fathy W, Abdel-Aziz MM, Ibrahim RE, Yehia A, et al. Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med. (2022) 23(4):774&#x2013;81. 10.1093/pm/pnab341</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab341</ArticleId><ArticleId IdType="pmc">PMC8755258</ArticleId><ArticleId IdType="pubmed">34931670</ArticleId></ArticleIdList></Reference><Reference><Citation>Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. (2017) 3:17002. 10.1038/nrdp.2017.2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.2</ArticleId><ArticleId IdType="pmc">PMC5371025</ArticleId><ArticleId IdType="pubmed">28205574</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. (2019) 76(10):1240&#x2013;51. 10.1001/jamaneurol.2019.2917</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2917</ArticleId><ArticleId IdType="pmc">PMC10021074</ArticleId><ArticleId IdType="pubmed">31498378</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. (2022) 9(3):e1146. 10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirthi V, Perumbalath A, Brown E, Nevitt S, Petropoulos IN, Burgess J, et al. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res. (2021) 9(1):e002040. 10.1136/bmjdrc-2020-002040</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2020-002040</ArticleId><ArticleId IdType="pmc">PMC8137250</ArticleId><ArticleId IdType="pubmed">34006607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando A, Miyamoto M, Saito N, Kotani K, Kamiya H, Ishibashi S, et al. Small fibre neuropathy is associated with impaired vascular endothelial function in patients with type 2 diabetes. Front Endocrinol. (2021) 12:653277. 10.3389/fendo.2021.653277</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.653277</ArticleId><ArticleId IdType="pmc">PMC8079951</ArticleId><ArticleId IdType="pubmed">33935969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. (2000) 54(6):1246&#x2013;52. 10.1212/WNL.54.6.1246</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.6.1246</ArticleId><ArticleId IdType="pubmed">10746593</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn MD, Tooke JE. Diabetic neuropathy and the microcirculation. Diabet Med. (1995) 12(4):298&#x2013;301. 10.1111/j.1464-5491.1995.tb00480.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.1995.tb00480.x</ArticleId><ArticleId IdType="pubmed">7600742</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yue L, Qiu J, Gao M, Liu S, Wang J. Endothelial dysfunction and platelet hyperactivation in diabetic complications induced by glycemic variability. Horm Metab Res . 2022;54(7):419&#x2013;28. 10.1055/a-1880-0978</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1880-0978</ArticleId><ArticleId IdType="pmc">PMC9282943</ArticleId><ArticleId IdType="pubmed">35835141</ArticleId></ArticleIdList></Reference><Reference><Citation>Pf&#xfc;tzner A, Forst T, Engelbach M, Margin T, Goitom K, L&#xf6;big M, et al. The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus. Diabet Med. (2021) 18(6):489&#x2013;94. 10.1046/j.1464-5491.2001.00524.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1464-5491.2001.00524.x</ArticleId><ArticleId IdType="pubmed">11472469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchler T, G&#xfc;nthner R, Ribeiro A, Hausinger R, Streese L, W&#xf6;hnl A, et al. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation. Angiogenesis. (2023) 26(4):547&#x2013;63. 10.1007/s10456-023-09885-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09885-6</ArticleId><ArticleId IdType="pmc">PMC10542303</ArticleId><ArticleId IdType="pubmed">37507580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20(1):172. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol. (2023) 24(10):1616&#x2013;27. 10.1038/s41590-023-01601-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. (2021) 41(8):BSR20210611. 10.1042/BSR20210611</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum M, Syritsyna O, Spitzer ED, Marcos LA. Neurologic manifestations of tick-borne diseases transmitted by deer ticks (Ixodes scapularis) in the USA. Curr Trop Med Rep. (2023) 10(4):213&#x2013;21. 10.1007/s40475-023-00302-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-023-00302-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrandi PJ, Alway SE, Mohamed JS. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J App Physiol. (2020) 129(4):864&#x2013;7. 10.1152/japplphysiol.00321.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00321.2020</ArticleId><ArticleId IdType="pmc">PMC7832004</ArticleId><ArticleId IdType="pubmed">32673162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>